The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Protein Nanoparticles: Promising Platforms for Drug Delivery Applications
Abstract
The development of drug delivery systems using nanoparticles as carriers for small and large therapeutic molecules remains a rapidly growing area of research. The advantages of using proteins to prepare nanoparticles for drug delivery applications include their abundance in natural sources, biocompatibility, biodegradability, easy synthesis process, and cost-effectiveness. In contrast to several particulate systems like nanoparticles from metallic and inorganic/synthetic sources, the protein nanoparticles do not have limitations such as potential toxicity, large size, accumulation, or rapid clearance from the body. In addition, protein-based nanoparticles offer the opportunity for surface modification by conjugation of other protein and carbohydrate ligands. This enables targeted delivery to the desired tissue and organ, which further reduces systemic toxicity. The use of protein nanoparticles for such applications could therefore prove to be a better alternative to maneuver and improve the pharmacokinetic and pharmacodynamic properties of the various types of drug molecules. In this review, while focusing on the properties of a few proteins such as the silk protein fibroin, we attempt to provide an overview of the existing protein-based nanoparticles. We discuss various methods for the synthesis of this class of nanoparticles. The review brings forth some of the factors that are important for the design of this class of nanoparticles and highlights the applications of the nanoparticles obtained from these proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Altman, G. H., Diaz, F., Jakuba, C., Calabro, T., Horan, R. L., Chen, J., Lu, H., Richmond, J., & Kaplan, D. L. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00353-8 · Cited by 3,458
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Chithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Lewis Phillips, G. D., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blättler, W. A., Lambert, J. M., Chari, R. V. J., Lutz, R. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1776 · Cited by 1,676
Malafaya, P. B., Silva, G. A., & Reis, R. L. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.012 · Cited by 1,401
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Advanced materials and processing for drug delivery: The past and the future
Zhang, Y., Chan, H. F., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.003 · Cited by 1,000
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Nanotechnology applications in cancer
Nie, S., Xing, Y., Kim, G. J., & Simons, J. W. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152025 · Cited by 952
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Bigi, A., Cojazzi, G., Panzavolta, S., Rubini, K., & Roveri, N. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00236-2 · Cited by 891
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
Silk fibroin as biomaterial for bone tissue engineering
Melke, J., Midha, S., Ghosh, S., Ito, K., & Hofmann, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.005 · Cited by 789
Silk fibroin: Structural implications of a remarkable amino acid sequence
Zhou, C., Confalonieri, F., Jacquet, M., Perasso, R., Li, Z., & Janin, J. (2001) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.1078 · Cited by 784
The protamine family of sperm nuclear proteins
Balhorn, R. (2007) · Genome Biology · doi:10.1186/gb-2007-8-9-227 · Cited by 773
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 773
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., & Schubert, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00134-0 · Cited by 757
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Fine organization of Bombyx mori fibroin heavy chain gene
Zhou, C.-Z. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.2413 · Cited by 711
The science and technology of gelatin
Veis, A. (1978) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(78)90323-5 · Cited by 703
The Crystal Structure of the Human Hepatitis B Virus Capsid
Wynne, S. A., Crowther, R. A., & Leslie, A. G. W. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80009-5 · Cited by 667
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
Nitta, S., & Numata, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011629 · Cited by 666
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Lohcharoenkal, W., Wang, L., Chen, Y. C., & Rojanasakul, Y. (2014) · BioMed Research International · doi:10.1155/2014/180549 · Cited by 655
McKay, W. F., Peckham, S. M., & Badura, J. M. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0418-6 · Cited by 616
Desolvation process and surface characterisation of protein nanoparticles
Weber, C., Coester, C., Kreuter, J., & Langer, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00370-1 · Cited by 603
Andrew MacKay, J., Chen, M., McDaniel, J. R., Liu, W., Simnick, A. J., & Chilkoti, A. (2009) · Nature Materials · doi:10.1038/nmat2569 · Cited by 580
Membrane models with phospholipids
Bangham, A. D. (1968) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(68)90019-9 · Cited by 544
Controlling silk fibroin particle features for drug delivery
Lammel, A. S., Hu, X., Park, S.-H., Kaplan, D. L., & Scheibel, T. R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.024 · Cited by 538
Protein‐Based Nanomedicine Platforms for Drug Delivery
MaHam, A., Tang, Z., Wu, H., Wang, J., & Lin, Y. (2009) · Small · doi:10.1002/smll.200801602 · Cited by 524
Micro- and nanoparticle production by electrospraying
Jaworek, A. (2007) · Powder Technology · doi:10.1016/j.powtec.2007.01.035 · Cited by 512
Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
Chawla, J. S., & Amiji, M. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00483-0 · Cited by 487
Protamine sulfate enhances lipid-mediated gene transfer
Sorgi, F., Bhattacharya, S., & Huang, L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300484 · Cited by 451
Brewer, J. M., Conacher, M., Hunter, C. A., Mohrs, M., Brombacher, F., & Alexander, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6448 · Cited by 440
Bovine spongiform encephalopathy: epidemiological studies on the origin
Wilesmith, J., Ryan, J., & Atkinson, M. (1991) · Veterinary Record · doi:10.1136/vr.128.9.199 · Cited by 438
A virus-based single-enzyme nanoreactor
Comellas-Aragonès, M., Engelkamp, H., Claessen, V. I., Sommerdijk, N. A. J. M., Rowan, A. E., Christianen, P. C. M., Maan, J. C., Verduin, B. J. M., Cornelissen, J. J. L. M., & Nolte, R. J. M. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.299 · Cited by 431
Shu, X. Z., & Zhu, K. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00403-8 · Cited by 423
Biomacromolecules as carriers in drug delivery and tissue engineering
Zhang, Y., Sun, T., & Jiang, C. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.005 · Cited by 416
Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease
Roney, C., Kulkarni, P., Arora, V., Antich, P., Bonte, F., Wu, A., Mallikarjuana, N. N., Manohar, S., Liang, H.-F., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 406
Silk-based delivery systems of bioactive molecules
Numata, K., & Kaplan, D. L. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.009 · Cited by 385
Tighe, H., Takabayashi, K., Schwartz, D., Van Nest, G., Tuck, S., Eiden, J. J., Kagey-Sobotka, A., Creticos, P. S., Lichtenstein, L. M., Spiegelberg, H. L., et al. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107927 · Cited by 385
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
Petkov, V., Mosgoeller, W., Ziesche, R., Raderer, M., Stiebellehner, L., Vonbank, K., Funk, G.-C., Hamilton, G., Novotny, C., Burian, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17500 · Cited by 352
Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles
Ashley, C. E., Carnes, E. C., Phillips, G. K., Durfee, P. N., Buley, M. D., Lino, C. A., Padilla, D. P., Phillips, B., Carter, M. B., Willman, C. L., et al. (2011) · ACS Nano · doi:10.1021/nn201397z · Cited by 350
Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery
Rohovie, M. J., Nagasawa, M., & Swartz, J. R. (2017) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10049 · Cited by 340
Silk fibroin nanoparticles for cellular uptake and control release
Kundu, J., Chung, Y.-I., Kim, Y. H., Tae, G., & Kundu, S. C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.052 · Cited by 336
Self-citationSilk Fibroin-Based Nanoparticles for Drug Delivery
Zhao, Z., Li, Y., & Xie, M.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034880 · Cited by 332
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
TAMBER, H., JOHANSEN, P., MERKLE, H., & GANDER, B. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.002 · Cited by 316
Protein nanoparticle: A unique system as drug delivery vehicles
Jahanshahi, M., & Babaei, Z. (2008) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.4314/ajb.v7i25.59701 · Cited by 314
Wang, Z., Zhang, Y., Zhang, J., Huang, L., Liu, J., Li, Y., Zhang, G., Kundu, S. C., & Wang, L. (2014) · Scientific Reports · doi:10.1038/srep07064 · Cited by 289
Self-citationStorni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1777 · Cited by 286
Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy
Gupta, V. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s5581 · Cited by 282
Cooley, M., Sarode, A., Hoore, M., Fedosov, D. A., Mitragotri, S., & Sen Gupta, A. (2018) · Nanoscale · doi:10.1039/c8nr04042g · Cited by 279
Nosrati, H., Sefidi, N., Sharafi, A., Danafar, H., & Kheiri Manjili, H. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.12.033 · Cited by 277
How to achieve sustained and complete protein release from PLGA-based microparticles?
Giteau, A., Venier-Julienne, M. C., Aubert-Pouëssel, A., & Benoit, J. P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.012 · Cited by 268
Applications of elastin-like polypeptides in drug delivery
MacEwan, S. R., & Chilkoti, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.028 · Cited by 261
Tian, Y., Jiang, X., Chen, X., Shao, Z., & Yang, W. (2014) · Advanced Materials · doi:10.1002/adma.201403562 · Cited by 258
Monitoring of inflammatory mediators induced by silk sericin
Aramwit, P., Kanokpanont, S., De-Eknamkul, W., & Srichana, T. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2008.12.012 · Cited by 257
Almine, J. F., Bax, D. V., Mithieux, S. M., Nivison-Smith, L., Rnjak, J., Waterhouse, A., Wise, S. G., & Weiss, A. S. (2010) · Chemical Society Reviews · doi:10.1039/b919452p · Cited by 256
Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy
Lu, Z., Yeh, T.-K., Tsai, M., Au, J. L.-S., & Wientjes, M. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1443 · Cited by 256
Role of pH and charge on silk protein assembly in insects and spiders
Foo, C. W. P., Bini, E., Hensman, J., Knight, D. P., Lewis, R. V., & Kaplan, D. L. (2006) · Applied Physics A · doi:10.1007/s00339-005-3426-7 · Cited by 252
Protein Based Nanostructures for Drug Delivery
Verma, D., Gulati, N., Kaul, S., Mukherjee, S., & Nagaich, U. (2018) · Journal of Pharmaceutics · doi:10.1155/2018/9285854 · Cited by 244
Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release
Herrero-Vanrell, R., Rincón, A. C., Alonso, M., Reboto, V., Molina-Martinez, I. T., & Rodríguez-Cabello, J. C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.001 · Cited by 241
Silk sericin and its applications: A review
Padamwar, M. N., & Pawar, A. (2004) · Journal of Scientific & Industrial Research · Cited by 237
McDaniel, J. R., Radford, D. C., & Chilkoti, A. (2013) · Biomacromolecules · doi:10.1021/bm4007166 · Cited by 222
Müller, R., Maaben, S., Weyhers, H., & Mehnert, W. (1996) · Journal of Drug Targeting · doi:10.3109/10611869609015973 · Cited by 222
Disposition Characteristics of Macromolecules in Tumor-Bearing Mice
Takakura, Y., Fujita, T., Hashida, M., & Sezaki, H. (1990) · Pharmaceutical Research · doi:10.1023/a:1015807119753 · Cited by 221
Balthasar, S., Michaelis, K., Dinauer, N., von Briesen, H., Kreuter, J., & Langer, K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.047 · Cited by 221
Estey, T., Kang, J., Schwendeman, S. P., & Carpenter, J. F. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20625 · Cited by 221
Drug delivery to solid tumors by elastin-like polypeptides
McDaniel, J. R., Callahan, D. J., & Chilkoti, A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.05.004 · Cited by 217
Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells
Steinhauser, I., Spänkuch, B., Strebhardt, K., & Langer, K. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.016 · Cited by 216
Bioengineered protein-based nanocage for drug delivery
Lee, E. J., Lee, N. K., & Kim, I.-S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.002 · Cited by 215
Anticoagulants and Their Reversal
Schulman, S., & Bijsterveld, N. R. (2007) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2006.08.002 · Cited by 212
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells
Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J., & Langer, K. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010697 · Cited by 211
Analysis of the Structure of Bombyx mori Silk Fibroin by NMR
Asakura, T., Okushita, K., & Williamson, M. P. (2015) · Macromolecules · doi:10.1021/acs.macromol.5b00160 · Cited by 210
Albumin microspheres for study of the reticuloendothelial system.
Scheffel, U., Rhodes, B. A., Natarajan, T. K., & Wagner, H. N. (1972) · PubMed · Cited by 207
Floss, D. M., Schallau, K., Rose-John, S., Conrad, U., & Scheller, J. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.10.004 · Cited by 206
Production of Curcumin-Loaded Silk Fibroin Nanoparticles for Cancer Therapy
Montalbán, M., Coburn, J., Lozano-Pérez, A., Cenis, J., Víllora, G., & Kaplan, D. (2018) · Nanomaterials · doi:10.3390/nano8020126 · Cited by 203
Gliadin nanoparticles for the controlled release of all-trans-retinoic acid
Ezpeleta, I., Irache, J. M., Stainmesse, S., Chabenat, C., Gueguen, J., Popineau, Y., & Orecchioni, A.-M. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04338-1 · Cited by 201
Vandelli, M. A., Rivasi, F., Guerra, P., Forni, F., & Arletti, R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00681-5 · Cited by 197
Jithan, A., Madhavi, K., Madhavi, M., & Prabhakar, K. (2011) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.82432 · Cited by 192
Silk sericin/polyacrylamide in situ forming hydrogels for dermal reconstruction
Kundu, B., & Kundu, S. C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.091 · Cited by 191
Self-citationTargeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles
Mishra, V., Mahor, S., Rawat, A., Gupta, P. N., Dubey, P., Khatri, K., & Vyas, S. P. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600612953 · Cited by 191
YANG, L., CUI, F., CUN, D., TAO, A., SHI, K., & LIN, W. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.028 · Cited by 190
Wang, H., Zou, Q., Boerman, O. C., Nijhuis, A. W. G., Jansen, J. A., Li, Y., & Leeuwenburgh, S. C. G. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.015 · Cited by 189
Solid lipid nanoparticles as drug carriers for topical glucocorticoids
Maia, C. S., Mehnert, W., & Schäfer-Korting, M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00413-5 · Cited by 188
Lomis, N., Westfall, S., Farahdel, L., Malhotra, M., Shum-Tim, D., & Prakash, S. (2016) · Nanomaterials · doi:10.3390/nano6060116 · Cited by 187
Gu, G., Xia, H., Hu, Q., Liu, Z., Jiang, M., Kang, T., Miao, D., Tu, Y., Pang, Z., Song, Q., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.044 · Cited by 184
Fibrous protein-based hydrogels for cell encapsulation
Silva, R., Fabry, B., & Boccaccini, A. R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.078 · Cited by 183
Designing protein-based biomaterials for medical applications
Gagner, J. E., Kim, W., & Chaikof, E. L. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.10.001 · Cited by 182
Escherichia coli‐based cell‐free synthesis of virus‐like particles
Bundy, B. C., Franciszkowicz, M. J., & Swartz, J. R. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21716 · Cited by 179
Protein Separation via Polyelectrolyte Coacervation: Selectivity and Efficiency
Wang, Y.-F., Gao, J. Y., & Dubin, P. L. (1996) · Biotechnology Progress · doi:10.1021/bp960013+ · Cited by 176
Silk: Biology, Structure, Properties, and Genetics
Kaplan, D. L., Adams, W. W., Farmer, B. L., & Viney, C. (1993) · ACS symposium series · doi:10.1021/bk-1994-0544.ch001 · Cited by 172
Protein-based nanoparticles in cancer vaccine development
Neek, M., Kim, T. I., & Wang, S.-W. (2019) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2018.09.004 · Cited by 172
Elastin-like polypeptides in drug delivery
Rodríguez-Cabello, J. C., Arias, F. J., Rodrigo, M. A., & Girotti, A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.007 · Cited by 169
Maeda, M., Tani, S., Sano, A., & Fujioka, K. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00156-x · Cited by 163
Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate
Bajpai, A. K., & Choubey, J. (2006) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-006-8235-9 · Cited by 161
Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting
Tseng, C.-L., Wang, T.-W., Dong, G.-C., Yueh-Hsiu Wu, S., Young, T.-H., Shieh, M.-J., Lou, P.-J., & Lin, F.-H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.006 · Cited by 160
Mandal, B. B., & Kundu, S. C. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/35/355101 · Cited by 158
Self-citationSilk sericin ameliorates wound healing and its clinical efficacy in burn wounds
Aramwit, P., Palapinyo, S., Srichana, T., Chottanapund, S., & Muangman, P. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1371-4 · Cited by 154
Preparation of Sub-100 nm Human Serum Albumin Nanospheres Using a pH-Coacervation Method
Lin, W., Coombes, A. G. A., Davies, M. C., et al. (1993) · Journal of drug targeting · doi:10.3109/10611869308996081 · Cited by 152
Genome‐Free Viral Capsids as Multivalent Carriers for Taxol Delivery
Wu, W. C. H., Hsiao, S. C., Carrico, Z. M., & Francis, M. B. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200902426 · Cited by 151
Elastin-like polypeptides as a promising family of genetically-engineered protein based polymers
Kowalczyk, T., Hnatuszko-Konka, K., Gerszberg, A., & Kononowicz, A. K. (2014) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-014-1649-5 · Cited by 149
Dash, B. C., Mandal, B. B., & Kundu, S. C. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.09.019 · Cited by 143
Self-citationMS2 Viruslike Particles: A Robust, Semisynthetic Targeted Drug Delivery Platform
Galaway, F. A., & Stockley, P. G. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3003368 · Cited by 143
Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique
Müller, B. G., Leuenberger, H., & Kissel, T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016064930502 · Cited by 142
Structural Study of Irregular Amino Acid Sequences in the Heavy Chain of Bombyx m ori Silk Fibroin
Ha, S.-W., Gracz, H. S., Tonelli, A. E., & Hudson, S. M. (2005) · Biomacromolecules · doi:10.1021/bm050294m · Cited by 142
Efficiency of resveratrol-loaded sericin nanoparticles: Promising bionanocarriers for drug delivery
Suktham, K., Koobkokkruad, T., Wutikhun, T., & Surassmo, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.015 · Cited by 141
Xu, Z. C., Wang, X., Xie, C., Wu, W., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.061 · Cited by 140
Arangoa, M. A., Campanero, M. Á., Renedo, M. J., Ponchel, G., & Irache, J. M. (2001) · Pharmaceutical Research · doi:10.1023/a:1013018111829 · Cited by 138
Drug loading and release on tumor cells using silk fibroin–albumin nanoparticles as carriers
Subia, B., & Kundu, S. C. (2012) · Nanotechnology · doi:10.1088/0957-4484/24/3/035103 · Cited by 138
Self-citationOsmolyte-Mediated Encapsulation of Proteins inside MS2 Viral Capsids
Glasgow, J. E., Capehart, S. L., Francis, M. B., & Tullman‐Ercek, D. (2012) · ACS Nano · doi:10.1021/nn302183h · Cited by 137
Mao, B., Liu, C., Zheng, W., Li, X., Ge, R., Shen, H., Guo, X., Lian, Q., Shen, X., & Li, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.045 · Cited by 137
Silk nanoparticles: from inert supports to bioactive natural carriers for drug delivery
Crivelli, B., Perteghella, S., Bari, E., Sorrenti, M., Tripodo, G., Chlapanidas, T., & Torre, M. L. (2017) · Soft Matter · doi:10.1039/c7sm01631j · Cited by 132
Development of a microRNA delivery system based on bacteriophage MS2 virus‐like particles
Pan, Y., Zhang, Y., Jia, T., Zhang, K., Li, J., & Wang, L. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08512.x · Cited by 129
Reguera, J., Urry, D. W., Parker, T. M., McPherson, D. T., & Rodríguez‐Cabello, J. C. (2007) · Biomacromolecules · doi:10.1021/bm060936l · Cited by 129
Bioadhesive potential of gliadin nanoparticulate systems
Arangoa, M. A., Ponchel, G., Orecchioni, A. M., Renedo, M. J., Duchêne, D., & Irache, J. M. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00121-4 · Cited by 129
Degradation Behavior of Silk Nanoparticles─Enzyme Responsiveness
Wongpinyochit, T., Johnston, B. F., & Seib, F. P. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b01021 · Cited by 128
Fan, Y., Wang, Y., Fan, Y., et al. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.062 · Cited by 126
Serum albumins—Unusual allergens
Chruszcz, M., Mikołajczak, K., Mank, N. J., Majorek, K. A., Porebski, P. J., & Minor, W. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.016 · Cited by 125
Targeted Albumin-Based Nanoparticles for Delivery of Amphipathic Drugs
Xu, R., Fisher, M. H., & Juliano, R. L. (2011) · Bioconjugate Chemistry · doi:10.1021/bc1002295 · Cited by 125
Umamaheshwari, R. B., Ramteke, S., & Jain, N. K. (2004) · AAPS PharmSciTech · doi:10.1208/pt050232 · Cited by 125
Insulin Preparations with Prolonged Effect
Owens, D. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0068 · Cited by 123
Temperature sensitive peptides: Engineering hyperthermia-directed therapeutics
MacKay, J. A., & Chilkoti, A. (2008) · International Journal of Hyperthermia · doi:10.1080/02656730802149570 · Cited by 122
Huang, L., Tao, K., Liu, J., Qi, C., Xu, L., Chang, P., Gao, J., Shuai, X., Wang, G., Wang, Z., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11617 · Cited by 122
Silk fibroin nanoparticles: Efficient vehicles for the natural antioxidant quercetin
Pérez, A. A. L., Rivero, H. C., Hernández, M. D. C. P., Pagán, A., Montalbán, M. G., Víllora, G., & Cenís, J. L. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.046 · Cited by 121
Mottaghitalab, F., Kiani, M., Farokhi, M., Kundu, S. C., Reis, R. L., Gholami, M., Bardania, H., Dinarvand, R., Geramifar, P., Beiki, D., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10408 · Cited by 119
Self-citationCollagen microparticles: Preparation and properties
Rössler, B., Kreuter, J., & Scherer, D. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509051126 · Cited by 115
Patterson, D. P., Schwarz, B. H., El‐Boubbou, K., John van der, O. O. S. T., Prevelige, P. E., & Douglas, T. (2012) · Soft Matter · doi:10.1039/c2sm26485d · Cited by 115
Efficient disulfide bond formation in virus-like particles
Bundy, B. C., & Swartz, J. R. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.04.011 · Cited by 113
5-Fluorouracil-Loaded BSA Nanoparticles: Formulation Optimization and In Vitro Release Study
Maghsoudi, A., Shojaosadati, S. A., & Vasheghani‐Farahani, E. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9146-5 · Cited by 112
Umamaheshwari, R. B., & Jain, N. K. (2003) · Journal of drug targeting · doi:10.1080/10611860310001647771 · Cited by 110
Nanospheres-Incorporated Implantable Hydrogel as a Trans-Tissue Drug Delivery System
Ding, D., Zhu, Z., Li, R., Li, X., Wu, W., Jiang, X., & Liu, B. (2011) · ACS Nano · doi:10.1021/nn102138u · Cited by 110
Noorani, L., Stenzel, M. H., Liang, R., Pourgholami, M. H., & Morris, D. L. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0082-8 · Cited by 109
Vogelbruch, M., Nuß, B., Körner, M., Kapp, A., Kiehl, P., & Bohm, W. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00501.x · Cited by 108
Wu, P., Liu, Q., Li, R., Wang, J., Xu, Z. C., Yue, G., Wang, H., Cui, F., Wu, F., Yang, M., et al. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am403992b · Cited by 108
Biodegradation of elastin‐like polypeptide nanoparticles
Shah, M. S., Hsueh, P., Sun, G., Chang, H. Y., Janib, S. M., & MacKay, J. A. (2012) · Protein Science · doi:10.1002/pro.2063 · Cited by 107
Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method
Li†, J. K., Wang, N., & Wu, X. S. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006846 · Cited by 107
Farrell, L.-L., Pepin, J., Kucharski, C., Lin, X., Xu, Z., & Uludağ, H. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.026 · Cited by 105
MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice
Pan, Y., Jia, Zhang, Zhang, Zhang, Li, & Wang, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s37990 · Cited by 103
Gawde, K. A., Sau, S., Tatiparti, K., Kashaw, S. K., Mehrmohammadi, M., Azmi, A. S., & Iyer, A. K. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.03.046 · Cited by 103
Silk sericin–insulin bioconjugates: Synthesis, characterization and biological activity
Zhang, Y., Ma, Y., Xia, Y., Shen, W., Mao, J.-P., & Xue, R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.019 · Cited by 102
Elastin‐like recombinamers: Biosynthetic strategies and biotechnological applications
Girotti, A., Fernández‐Colino, A., López, I. M., et al. (2011) · Biotechnology Journal · doi:10.1002/biot.201100116 · Cited by 99
Plant virus-based materials for biomedical applications: Trends and prospects
Eiben, S., Koch, C., Altintoprak, K., Southan, A., Tovar, G. E. M., Laschat, S., Weiss, I. M., & Wege, C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.011 · Cited by 99
Narayanan, D., Geena, M. G., Lakshmi, H., Koyakutty, M., Nair, S. V., & Menon, D. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.02.001 · Cited by 96
Antisense delivery using protamine-oligonucleotide particles
Junghans, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.10.e45 · Cited by 96
Sharma, S., Bano, S., Ghosh, A. S., Mandal, M., Kim, H., Dey, T., & Kundu, S. C. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.12.385 · Cited by 93
Self-citationPerteghella, S., Crivelli, B., Catenacci, L., Sorrenti, M., Bruni, G., Necchi, V., Vigani, B., Sorlini, M., Torre, M. L., & Chlapanidas, T. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.005 · Cited by 92
Polyethylenimine‐coated albumin nanoparticles for BMP‐2 delivery
Zhang, S., Wang, G., Lin, X., Chatzinikolaidou, Μ., Jennissen, H. P., Laub, M., & Uludağ, H. (2008) · Biotechnology Progress · doi:10.1002/btpr.12 · Cited by 91
Formulating Paclitaxel in Nanoparticles Alters Its Disposition
Yeh, T. K., Lu, Z., Wientjes, M. G., & Au, J. L. ‐. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4581-4 · Cited by 90
Nicklas, M., Schatton, W. F. H., Heinemann, S., Hanke, T., & Kreuter, J. (2009) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040902755213 · Cited by 90
Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System
Qazi, S., Miettinen, H. M., Wilkinson, R. A., McCoy, K., Douglas, T., & Wiedenheft, B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00822 · Cited by 88
Maitz, M. F., Sperling, C., Wongpinyochit, T., Herklotz, M., Werner, C., & Seib, F. P. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.07.012 · Cited by 88
Prel, A., Caval, V., Gayon, R., Ravassard, P., Duthoit, C. T., Payen, E., Maouche-Chretien, L., Crénéguy, A., Nguyen, T. H., Martin, N., et al. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2015.39 · Cited by 87
Yan, H., Zhang, Y., Ma, Y.-L., & Zhou, L.-X. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9549-y · Cited by 86
Ezpeleta, I., Arangoa, M. A., Irache, J. M., Stainmesse, S., Chabenat, C., Popineau, Y., & Orecchioni, A. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00232-x · Cited by 85
Intelligent Biosynthetic Nanobiomaterials (IBNs) for Hyperthermic Gene Delivery
Chen, T.-H. H., Bae, Y., & Furgeson, D. Y. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9382-5 · Cited by 84
Ding, D., Zhu, Z., Liu, Q., Wang, J., Hu, Y., Jiang, X., & Li, R. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.008 · Cited by 84
Engineered Mutations Change the Structure and Stability of a Virus-Like Particle
Fiedler, J. D., Higginson, C. J., Hovlid, M. L., Kislukhin, A. A., Castillejos, A. G., Manzenrieder, F., Campbell, M. G., Voss, N. R., Potter, C. S., Carragher, B. O., et al. (2012) · Biomacromolecules · doi:10.1021/bm300590x · Cited by 84
Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles
Hovlid, M. L., Lau, J. L., Breitenkamp, K., Higginson, C. J., Laufer, B., Manchester, M., & Finn, M. G. (2014) · ACS Nano · doi:10.1021/nn502043d · Cited by 84
Paclitaxel‐loaded silk fibroin nanospheres
Chen, M., Shao, Z., & Chen, X. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33265 · Cited by 82
Bano, S., Dey, T., Sharma, S., & Kundu, S. C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am506094c · Cited by 81
Self-citationFabrication of sericin nanoparticles for controlled gene delivery
Das, S. K., Dey, T., & Kundu, S. C. (2013) · RSC Advances · doi:10.1039/c3ra44990d · Cited by 78
Self-citationElastin‐Like Polypeptide Based Nanoparticles: Design Rationale Toward Nanomedicine
Smits, F. C. M., Buddingh’, B. C., van Eldijk, M. B., & van Hest, J. C. M. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201400419 · Cited by 77
Nisha, C. K., Manorama, S. V., Ganguli, M., Maiti, S., & Kizhakkedathu, J. N. (2004) · Langmuir · doi:10.1021/la035737r · Cited by 75
Anand, P., O’Neil, A., Lin, E. P.-Y., Douglas, T., & Holford, M. (2015) · Scientific Reports · doi:10.1038/srep12497 · Cited by 75
Yang, X., Yang, S., Chai, H., Yang, Z., Lee, R. J., Liao, W., & Teng, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136649 · Cited by 74
In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide
Simnick, A. J., Amiram, M., Liu, W., Hanna, G., Dewhirst, M. W., Kontos, C. D., & Chilkoti, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.044 · Cited by 74
Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery
Xu, L., He, X., Liu, B., Xu, C., Ai, S., Zhuo, R., & Cheng, S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.07.008 · Cited by 73
Predicting the Loading of Virus-Like Particles with Fluorescent Proteins
Rurup, W. F., Verbij, F. C., Koay, M. S. T., Blum, C., Subramaniam, V., & Cornelissen, J. J. L. M. (2013) · Biomacromolecules · doi:10.1021/bm4015792 · Cited by 70
Elastin-like polypeptides and their applications in anticancer drug delivery systems: a review
Saxena, R., & Nanjan, M. J. (2013) · Drug Delivery · doi:10.3109/10717544.2013.853210 · Cited by 68
Stabilization of Dichloromethane-Induced Protein Denaturation During Microencapsulation
Raghuvanshi, R. S., Goyal, S., Singh, O., et al. (1998) · Pharmaceutical Development and Technology · doi:10.3109/10837459809028504 · Cited by 68
The development and characterization of SDF1α-elastin-like-peptide nanoparticles for wound healing
Yeboah, A., Cohen, R. I., Faulknor, R., Schloss, R. S., Yarmush, M. L., & Francois Berthiaume, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.020 · Cited by 68
Hu, D., Li, T., Xu, Z., Liu, D., Yang, M., & Zhu, L. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.024 · Cited by 68
Current approaches to stabilising and analysing proteins during microencapsulation in PLGA
van der Walle, C. F., Sharma, G., & Kumar, M. N. V. R. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802680169 · Cited by 67
Ramteke, S., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860701733278 · Cited by 67
Kanoujia, J., Singh, M. V., Singh, P., & Saraf, S. A. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.08.011 · Cited by 67
Fabrication of silk fibroin nanoparticles for controlled drug delivery
Zhao, Z., Chen, A., Li, Y., Hu, J., Liu, X., Li, J., Zhang, Y., Li, G., & Zheng, Z. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0736-5 · Cited by 65
Singh, A., Xu, J., Mattheolabakis, G., & Amiji, M. M. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.11.010 · Cited by 65
Computational smart polymer design based on elastin protein mutability
Tarakanova, A., Huang, W., Weiss, A. S., Kaplan, D. L., & Buehler, M. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.041 · Cited by 65
Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method
Irache, J. M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04103-6 · Cited by 64
Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery
Buehler, D. C., Marsden, M. D., Shen, S., Toso, D. B., Wu, X., Loo, J. A., Zhou, Z. H., Kickhoefer, V. A., Wender, P. A., Zack, J. A., et al. (2014) · ACS Nano · doi:10.1021/nn5002694 · Cited by 64
Rodríguez‐Nogales, A., Algieri, F., Matteis, L. D., Pérez, A. A. L., Garrido‐Mesa, J., Vezza, T., de la Fuente, J. M., Cenís, J. L., Gálvez, J., & Rodríguez‐Cabezas, M. E. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s116479 · Cited by 63
Nejat, H., Rabiee, M., Varshochian, R., Tahriri, M., Jazayeri, H. E., Rajadas, J., Ye, H., Cui, Z., & Tayebi, L. (2017) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2017.09.008 · Cited by 62
Weyermann, J., Lochmann, D., Georgens, C., & Zimmer, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.07.014 · Cited by 60
Pali-Schöll, I., Szöllösi, H., Starkl, P., Scheicher, B., Stremnitzer, C., Hofmeister, A., Roth-Walter, F., Lukschal, A., Diesner, S., Zimmer, A., et al. (2013) · European journal of pharmaceutics and biopharmaceutics · doi:10.1016/j.ejpb.2013.03.003 · Cited by 59
Freitas, G. B. L. D., de Almeida, D. J., Carraro, E., Kerppers, I. I., Martins, G. A. G., Mainardes, R. M., Khalil, N. M., & Messias-Reason, I. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.07.064 · Cited by 59
Wu, P., Liu, Q., Wang, Q., Qian, H., Yu, L., Liu, B., & Li, R. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166104 · Cited by 59
Lagoutte, P., Mignon, C., Donnat, S., Stadthagen, G., Mast, J., Sodoyer, R., Lugari, A., & Werle, B. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.02.011 · Cited by 58
Assembly, Engineering and Applications of Virus-Based Protein Nanoparticles
Mateu, M. G. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39196-0_5 · Cited by 57
Zaman, R. U., Mulla, N. S., Gomes, K. B., D’Souza, C., Murnane, K. S., & D’Souza, M. J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.043 · Cited by 56
Fluorescent silk fibroin nanoparticles prepared using a reverse microemulsion
Myung, S. J., Kim, H.-S., Kim, Y., Chen, P., & Jin, H. (2008) · Macromolecular Research · doi:10.1007/bf03218567 · Cited by 55
Genome-free Viral Capsids as Carriers for Positron Emission Tomography Radiolabels
Hooker, J. M., O’Neil, J. P., Romanini, D. W., Taylor, S. E., & Francis, M. B. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0136-5 · Cited by 55
Engineering of Brome mosaic virus for biomedical applications
Yıldız, İ., Tsvetkova, I. B., Wen, A. M., Shukla, S., Hema, M., Dragnea, B. G., & Steinmetz, N. F. (2012) · RSC Advances · doi:10.1039/c2ra01376b · Cited by 55
Cited by
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Biocompatibility of nanomaterials and their immunological properties
Kyriakides, T. R., Raj, A., Tseng, T. H., Xiao, H., Nguyen, R., Mohammed, F. S., Halder, S., Xu, M., Wu, M. J., Bao, S., et al. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe5fa · Cited by 389
Recent advances in natural polymer-based drug delivery systems
Tong, X., Pan, W., Su, T., Zhang, M., Dong, W., & Qi, X. (2020) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2020.104501 · Cited by 349
Nanoparticles: Synthesis, characteristics, and applications in analytical and other sciences
Sajid, M., & Płotka-Wasylka, J. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.104623 · Cited by 285
Metadata
- Authors
- Jain, A., Singh, S. K., Arya, S. K., Kundu, S. C., & Kapoor, S.
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-02
- Volume
- 4
- Issue
- 12
- Pages
- 3939-3961
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W2899515413
- Cited by
- 308
- References
- 232
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.